Discovery of arginine-containing tripeptides as a new class of pancreatic lipase inhibitors

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Kopelman PG. Obesity as a medical problem. Nature 404(6778), 635–643 (2000).
  Medline CASGoogle Scholar
• 2 Astrup A, Dyerberg J, Selleck M, Stender S. Nutrition transition and its relationship to the development of obesity and related chronic diseases. Obes. Rev. 9(1), 48–52 (2008).
  MedlineGoogle Scholar
• 3 Abbasi F, Brown BW Jr, Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. JACC 40(5), 937–943 (2002).
  Medline CASGoogle Scholar
• 4 Li MF, Cheung BM. Rise and fall of anti-obesity drugs. World J. Diabetes 2(2), 19–23 (2011).
  MedlineGoogle Scholar
• 5 Schrag JD, Li Y, Wu S, Cygler M. Lipases: Structure, Mechanism and Genetic Engineering.. In: GBF-monographs no. 16. Alberghina L, Schmid RD, Verger R (Eds). Wiley-VCH, Weinheim, Germany, 55–58 (1999).
  Google Scholar
• 6 Woolley P, Petersen SB (Eds). Lipases: Their Structure, Biochemistry and Applications. Cambridge University Press, Cambridge, England, 181–183 (1994).
  Google Scholar
• 7 Aloulou A, Rodriguez JA, Fernandez S, Van Oosterhout D, Puccinelli D, Carriere F. Exploring the specific features of interfacial enzymology based on lipase studies. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 1761, 995–1013 (2006).
  Medline CASGoogle Scholar
• 8 Verger R, Mieras MCE, de Haas GH. Action of phospholipase A at interfaces. J. Biol. Chem. 248(11), 4023–4034 (1973).
  Medline CASGoogle Scholar
• 9 Panaitov I, Verger R. Enzymatic reactions at interfaces: interfacial and temporal organization of enzymatic lipolysis. In: Physical Chemistry of Biological Interfaces. Baszkin A, Norde W (Eds). Marcel Dekker Inc., New York, Basel, 359–400 (2000).
  Google Scholar
• 10 Rietsch J, Pattus F, Desnuelle P, Verger R. Further studies of mode of action of lipolytic enzymes. J. Biol. Chem. 252(12), 4313–4318 (1977).
  Medline CASGoogle Scholar
• 11 Cotes K, Bakala N'goma JC, Dhouib R et al. Lipolytic enzymes in Mycobacterium tuberculosis. Appl. Microbiol. Biotechnol. 78(5), 741–749 (2008).
  Medline CASGoogle Scholar
• 12 Jaeger K-E, Ransac S, Dijkstra BW, Colson C, Vanheuvel M, Misset O. Bacterial lipases. FEMS Microbiol. Rev. 15(1), 29–63 (1994).
  Medline CASGoogle Scholar
• 13 Gilbert EJ. Pseudomonas lipases: biochemical properties and molecular cloning. Enzyme Microb. Technol. 15(8), 634–645 (1993).
  Medline CASGoogle Scholar
• 14 Huang AHC. Plant lipases. In: Lipases. Borgström B, Brockman HL (Eds). Elsevier, Amsterdam, The Netherlands, 419–442 (1984).
  Google Scholar
• 15 Mukherjee KD, Hills MJ. Lipases from plants. In: Lipases: Their Structure, Biochemistry and Application. Woolley P, Petersen SB (Eds). Cambridge University Press, Cambridge, England, 49–75 (1994).
  Google Scholar
• 16 Carrière F, Bezzine S, Verger R. Molecular evolution of the pancreatic lipase and two related enzymes towards different substrate selectivities. J. Mol. Catal. B. Enzym. 3, 55–64 (1997).
  CASGoogle Scholar
• 17 Carrière F, Gargouri Y, Moreau H, Ransac S, Rogalska E, Verger R. Gastric lipases: cellular, biochemical and kinetic aspects. In: Lipases: Their Structure, Biochemistry and Application. Woolley P, Petersen SB (Eds). Cambridge University Press, Cambridge, England, 181–205 (1994).
  Google Scholar
• 18 Zechner R, Zimmermann R, Eichmann TO et al. FAT SIGNALS-Lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 15(3), 279–291 (2012). • An overview on lipases and lipolysis in lipid metabolism and signaling.
  Medline CASGoogle Scholar
• 19 Hamosh M, Klaevman HL, Wolf RO, Scow RO. Pharyngeal lipase and digestion of dietary triglyceride in man. J. Clin. Invest. 55, 908–913 (1975).
  Medline CASGoogle Scholar
• 20 Rudd ER, Brockman HL. Pancreatic carboxylester lipase. In: Lipases. Borgstrom B, Brockman HL (Eds). Elsevier, Amsterdam, The Netherlands, 185–204 (1984).
  Google Scholar
• 21 Carrière F, Renou C, Ransac S et al. Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers. Am. J. Physiol. Gastrointest. Liver Physiol. 281(1), G16–G28 (2001).
  Medline CASGoogle Scholar
• 22 Tiss A, Lengsfeld H, Verger R. A comparative kinetic study on human pancreatic and Thermomyces lanuginosa lipases: inhibitory effects of tetrahydrolipstatin in the presence of lipid substrates. J. Mol. Catal. B. Enzym. 62, 19–26 (2010).
  CASGoogle Scholar
• 23 Lengsfeld H, Beaumier-Gallon G, Chahinian H et al. Physiology of gastrointestinal lipolysis and therapeutical use of lipases and digestive lipase inhibitors. In: Lipases and Phospholipases in Drug Development. Müller G, Petry S (Eds). Wiley-VCH, Weinheim, Germany, 195–223 (2004).
  Google Scholar
• 24 Liu X, Wang Y, Duclos RI Jr, O'Doherty GA. Stereochemical structure activity relationship studies (S-SAR) of tetrahydrolipstatin. ACS Med. Chem. Lett. 9(3), 274–278 (2018). •• Tetrahydrolipstatin and its analogs were evaluated as inhibitors of the hydrolysis of p-nitrophenyl butyrate by porcine pancreatic lipase. IC50 values are in the range of 4.0–930 nM. All compounds were also tested against three human cancer cell lines (human breast cancers MCF-7 and MDA-MB-231, human large-cell lung carcinoma H460).
  Medline CASGoogle Scholar
• 25 Point V, Kumar KVP, Marc S et al. Analysis of the discriminative inhibition of mammalian digestive lipases by 3-phenyl substituted 1,3,4-oxadiazol-2(3H)-ones. Eur. J. Med. Chem. 58, 452–463 (2012). • These inhibitors could be used for a better understanding of individual lipase function as well as for drug development aiming at the regulation of the whole gastrointestinal lipolysis process.
  Medline CASGoogle Scholar
• 26 Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS. Orlistat-associated adverse effects and drug interactions: a critical review. Drug Saf. 31(1), 53–65 (2008). •• This review described orlistat-associated adverse effects and drug interactions from a clinical and pathogenetic point of view.
  Medline CASGoogle Scholar
• 27 Kose M, Emet S, Akpinar TS et al. An unexpected result of obesity treatment: orlistat-related acute pancreatitis. Case Rep. Gastroenterol. 9(2), 152–155 (2015). • These authors reported the in vivo effects of orlistat administration in the early stages of acute pancreatitis documented by imaging, with enhancing of serum amylase levels.
  MedlineGoogle Scholar
• 28 Verger R. Pancreatic lipase. In: Lipase. Borgstrom B, Brockman HL (Eds). Elsevier, Amsterdam, The Netherlands, 83–105 (1984).
  Google Scholar
• 29 Embleton JK, Pouton CW. Structure and function of gastrointestinal lipases. Adv. Drug Deliv. Rev. 25, 15–32 (1997).
  CASGoogle Scholar
• 30 De Caro J, Boudouard M, Bonicel J, Guidoni A, Desnuelle P, Rovery M. Porcine pancreatic lipase. Completion of the primary structure. Biochim. Biophys. Acta 671, 129–138 (1981).
  Medline CASGoogle Scholar
• 31 Lowe ME, Rosenblum JL, Strauss WA. Cloning and characterization of human pancreatic lipase cDNA. J. Biol. Chem. 264, 20042–20048 (1989).
  Medline CASGoogle Scholar
• 32 Kerfelec B, Foglizzo E, Bonicel J, Bougis PE, Chapus C. Sequence of horse pancreatic lipase as determined by protein and cDNA sequencing. Implications for p-nitrophenyl acetate hydrolysis by pancreatic lipases. Eur. J. Biochem. 206, 279–287 (1992).
  Medline CASGoogle Scholar
• 33 Aleman-Gomez JA, Colwell NC, Sasser TL, Kumar VB. Molecular cloning and characterization of rabbit pancreatic triglyceride lipase. Biochem. Biophys. Res. Commun. 188, 964–971 (1992).
  Medline CASGoogle Scholar
• 34 Sims HF, Strauss AW, Lowe ME (1992). Genbank accession number M-58369. https://www.ncbi.nlm.nih.gov/genbank/.
  Google Scholar
• 35 Carrière F, Thirstrup K, Hjorth S, Boel E. Cloning of the classical guinea pig pancreatic lipase and comparison with the lipase related protein 2. FEBS Lett. 338, 63–68 (1994).
  Medline CASGoogle Scholar
• 36 Thirstrup K, Carrière F, Hjorth SA et al. Cloning and expression in insect cells of two pancreatic lipases and a procolipase from Myocastor coypus. Eur. J. Biochem. 227, 186–193 (1995).
  Medline CASGoogle Scholar
• 37 Wishart MJ, Andrews PC, Nichols R, Blevins GT Jr, Logsdon CD, Williams JA. Identification and cloning of GP-3 from rat pancreatic acinar zymogen granules as a glycosylated membrane-associated lipase. J. Biol. Chem. 268(14), 10303–10311 (1993).
  Medline CASGoogle Scholar
• 38 Giller T, Buchwald P, Blum-Kaelin D, Hunziker W. Two novel human pancreatic lipase related proteins, hPLRP1 and hPLRP2. Differences in colipase dependence and in lipase activity. J. Biol. Chem. 267, 16509–16516 (1992).
  Medline CASGoogle Scholar
• 39 Hjorth A, Carrière F, Cudrey C et al. A structural domain (the lid) found in pancreatic lipases is absent in the guinea pig (phospho)lipase. Biochemistry 32(18), 4702–4707 (1993).
  Medline CASGoogle Scholar
• 40 Thirstrup K, Verger R, Carrière F. Evidence for a pancreatic lipase subfamily with new kinetic properties. Biochemistry 33(10), 2748–2756 (1994).
  Medline CASGoogle Scholar
• 41 Winkler FK, D'Arcy A, Hunziker W. Structure of human pancreatic lipase. Nature 343(6260), 771–774 (1990).
  Medline CASGoogle Scholar
• 42 van Tilbeurgh H, Sarda L, Verger R, Cambillau C. Crystallographic study of the structure of colipase and of the interaction with pancreatic lipase. Nature 359(4), 159–162 (1992).
  Medline CASGoogle Scholar
• 43 Bourne Y, Martinez C, Kerfelec B, Lombardo D, Chapus C, Cambillau C. Horse pancreatic lipase. The crystal structure refined at 2.3 Å resolution. J. Mol. Biol. 238(5), 709–732 (1994).
  Medline CASGoogle Scholar
• 44 Mahe-Gouhier N, Lèger C. Immobilized colipase affinities for lipases B, A, C and their terminal peptide (336-449): the lipase recognition site lysine residues are located in the C-terminal region. Biochim. Biophys. Acta 962(1), 91–97 (1988).
  Medline CASGoogle Scholar
• 45 Abousalham A, Chaillan C, Kerfelec B, Foglizzo E, Chapus C. Uncoupling of catalysis and colipase binding in pancreatic lipase by limited proteolysis. Protein Eng. 5(1), 105–111 (1992).
  Medline CASGoogle Scholar
• 46 van Tilbeurgh H, Egloff M-P, Martinez C, Rugani N, Verger R, Cambillau C. Interfacial activation of the lipase-procolipase complex by mixed micelles revealed by X-ray crystallography. Nature 362(6423), 814–820 (1993). • The 3D structure of the lipase–procolipase complex, cocrystallized with mixed micelles of phosphatidylcholine and bile salt, has been determined at 3Å resolution by x-ray crystallography.
  Medline CASGoogle Scholar
• 47 Egloff MP, Marguet F, Buono G, Verger R, Cambillau C, van Tilbeurgh H. The 2.46 Å resolution structure of the pancreatic lipase-colipase complex inhibited by a C11 alkyl phosphonate. Biochemistry 34(9), 2751–2762 (1995).
  Medline CASGoogle Scholar
• 48 Egloff MP, Sarda L, Verger R, Cambillau C, van Tilbeurgh H. Crystallographic study of the structure of colipase and of the interaction with pancreatic lipase. Protein Sci. 4(1), 44–57 (1995).
  Medline CASGoogle Scholar
• 49 Charles M, Erlanson C, Bianchetta J, Joffre J, Guidoni A, Rovery M. The primary structure of porcine colipase II. I. The amino acid sequence. Biochim. Biophys. Acta 359(1), 186–197 (1974).
  Medline CASGoogle Scholar
• 50 Crenon I, Granon S, Chapus C, Kerfelec B. Molecular cloning and expression of two horse pancreatic cDNA encoding colipase A and B. Biochim. Biophys. Acta 1213(3), 357–360 (1994).
  Medline CASGoogle Scholar
• 51 Wicker C, Puigserver A. Rat pancreatic colipase mRNA: nucleotide sequence of a cDNA clone and nutritional regulation by a lipidic diet. Biochem. Biophys. Res. Commun. 167(1), 130–136 (1990).
  Medline CASGoogle Scholar
• 52 Fukuoka SI, Taniguchi Y, Kitagawa Y, Scheele G. Full length cDNA sequence encoding canine pancreatic colipase. Nucleic Acids Res. 18(18), 5549 (1990).
  Medline CASGoogle Scholar
• 53 Colwell NC, Aleman-Gomez JA, Sasser TL, Kumar VB. Molecular cloning and characterization of rabbit pancreatic triglyceride lipase. Biochem. Biophys. Res. Commun. 188(3), 964–971 (1992).
  MedlineGoogle Scholar
• 54 Granon S. Spectrofluorimetric study of the bile salt micelle binding site of pig and horse colipases. Biochim. Biophys. Acta 874(1), 54–60 (1986).
  Medline CASGoogle Scholar
• 55 Erlanson C, Barrowman JA, Borgström B. Chemical modifications of pancreatic colipase. Biochim. Biophys. Acta 489(1), 150–162 (1977).
  Medline CASGoogle Scholar
• 56 Chaillan C, Rogalska E, Chapus C, Lombardo D. A cross-linked complex between horse pancreatic lipase and colipase. FEBS Lett. 257(2), 443–446 (1989).
  Medline CASGoogle Scholar
• 57 Lowe ME. The triglyceride lipases of the pancreas. J. Lipid Res. 43(12), 2007–2016 (2002). • Pancreatic triglyceride lipase and colipase are necessary for efficient dietary triglyceride digestion. Pancreatic acinar cells also produce two pancreatic lipase proteins, namely PLRP1 and PLRP2, which have a great sequence similarity and structural homology with pancreatic triglyceride lipase.
  Medline CASGoogle Scholar
• 58 Brokerhoff H. On the function of bile salts and proteins as cofactors of lipase. J. Bwl. Chem. 246(18), 5828–5831 (1971).
  Google Scholar
• 59 Gargouri Y, Julien R, Sugihara A, Verger R, Sarda L. Inhibition of pancreatic and microbial lipase by proteins. Biochim. Biophys. Acta 795(2), 326–331 (1984).
  Medline CASGoogle Scholar
• 60 Gargouri Y, Pieroni G, Rivière C, Sugihara A, Sarda L, Verger R. Inhibition of lipase by proteins. A kinetic study with dicaprin monolayers. J. Biol. Chem. 260(4), 2268–2273 (1985).
  Medline CASGoogle Scholar
• 61 Tsujita T, Matsuura Y, Okuda H. Studies on the inhibition of pancreatic and carboxylester lipases by protamine. J. Lipid Res. 37(7), 1481–1487 (1996).
  Medline CASGoogle Scholar
• 62 Mollica A, Costante R, Novellino E et al. Design, synthesis and biological evaluation of two opioid agonist and Cav 2.2 blocker multitarget ligands. Chem. Biol. Drug Des. 86(2), 156–162 (2015).
  Medline CASGoogle Scholar
• 63 Mollica A, Zengin G, Durdagi S et al. Combinatorial peptide library screening for discovery of diverse α-glucosidase inhibitors using molecular dynamics simulations and binary QSAR models. J. Biomol. Struct. Dyn. doi:10.1080/07391102.2018.1439403, 1–15 (2018) (Epub ahead of print). •• Molecular dynamics (MD) simulations were performed among the 12 top-ranked peptides considering the MD simulations on crystallographic inhibitor acarbose. The compounds with the lower RMSD variability in the MD were synthesized on solid-phase peptide synthesis and then used for in vitro biological assay. One of them has good inhibitory activity validating this strategy as a powerful tool to discover novel peptide inhibitors.
  Google Scholar
• 64 Roh C, Jung U. Screening of crude plant extracts with anti-obesity activity. Int. J. Mol. Sci. 13(2), 1710–1719 (2012).
  Medline CASGoogle Scholar
• 65 Uysal S, Zengin G, Locatelli M et al. Cytotoxic and enzyme inhibitory potential of two Potentilla species (P. speciosa L. and P. reptans Willd.) and their chemical composition. Front. Pharmacol. 8, 290 (2017).
  MedlineGoogle Scholar
• 66 Chen F, Liu H, Sun H et al. Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking. Phys. Chem. Chem. Phys. 18(32), 22129–22139 (2016).
  Medline CASGoogle Scholar
• 67 Zengin G, Lobine D, Mollica A, Locatelli M, Carradori S, Mahomoodally MF. Multiple pharmacological approaches on Fibigia eriocarpa extracts by in vitro and computational assays. Fundam. Clin. Pharmacol. 32(4), 400–413 (2018).
  Medline CASGoogle Scholar